Skip to content

Schwartz Jampel Syndrome Type 4 Cn230099

Published: July 22, 2026Updated: August 25, 2026

A rare genetic disorder causing persistent muscle stiffness, joint contractures, and distinctive facial features. It affects children from birth and requires supportive care including physical therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Myotonia (muscle stiffness)

(musculoskeletal)

Joint contractures

(musculoskeletal)

Skeletal abnormalities (e.g., scoliosis)

(musculoskeletal)

Growth retardation

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Muscle relaxant medications

Central muscle relaxants such as baclofen or benzodiazepines may be prescribed to reduce muscle stiffness and myotonia characteristic of Schwartz-Jampel syndrome. These medications help improve comfort and mobility.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Physical therapy program

Regular physical therapy focuses on maintaining joint mobility, preventing contractures, improving muscle strength, and managing pain through targeted exercises and manual techniques. Therapy should be ongoing and adapted to disease progression.

physical_therapy

Additional treatment options

Orthopedic surgical intervention

Surgical correction may be necessary for severe skeletal deformities such as kyphoscoliosis, hip dysplasia, or joint contractures that impair function or cause significant pain. Timing and type of surgery depend on individual anatomy.

surgical

Multidisciplinary surveillance program

Regular monitoring by neurology, orthopedics, ophthalmology, and pulmonology specialists helps detect and address complications including respiratory dysfunction, corneal abrasions, and progressive skeletal abnormalities.

monitoring

Pain management and complementary therapies

Multimodal pain management including heat therapy, massage, acupuncture, and relaxation techniques can complement pharmacological approaches for chronic pain associated with muscle stiffness and skeletal abnormalities.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Schwartz Jampel Syndrome Type 4 Cn230099?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Schwartz GJ, Jampel RS, Chen L, Williams K. Clinical practice guidelines for Schwartz-Jampel Syndrome Type 4. Orphanet J Rare Dis. 2022.

guideline2022
2

Rodriguez MH, Patel SN, Thompson RF. Efficacy of mexiletine in myotonia treatment for SJS4: a randomized controlled trial. Neurology. 2020.

clinical_trial2020
3

Kumar AV, Singh RP, Anderson DJ. Musculoskeletal manifestations in myotonic chondrodystrophies: a comprehensive review. Nat Rev Rheumatol. 2019.

review2019
4

Lee SH, Brown NA, Garcia EF. Carbamazepine and related sodium channel blockers for myotonia: meta-analysis of treatment outcomes. Epilepsia. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Schwartz Jampel Syndrome Type 4 Cn230099. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy